Pamala Pawloski
Clinical pharmacy researcher
pharmacy
HealthPartners Research Foundation
United States of America
Biography
Pamala Pawloski is Clinical pharmacy researcher at health partners institute. she completed her Pharm.D. North Dakota State University; pharmacy practice residency and oncology pharmacy practice residency, University of Kentucky; clinical pharmacology fellowship, University of Texas M.D. Anderson Cancer Center.
Research Interest
Oncology clinical pharmacy, clinical pharmacology, improving patient care and outcomes by improving medication management through enhanced identification of adverse reactions and subsequent reporting, increased medical therapy-management programs, and application of pharmacogenomic testing methods to enhance treatment optimization.
Publications
-
Chronic use of opioid medications before and after bariatric surgery. Raebel MA, Newcomer SR, Reifler LM, Boudreau D, Elliott TE, DeBar L, Ahmed A, Pawloski PA, Fisher D, Donahoo WT, Bayliss EA. JAMA. 2013; 310(13):1369-76.
-
Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Hansen C, Joski P, Freiman H, Andrade S, Toh S, Dublin S, Cheetham C, Cooper W, Pawloski P, Li DK, Beaton S, Kaplan S, Scott P, Hammad T, Davis R. Maternal and child health journal. 2013; 17(9):1611-21. NIHMSID: NIHMS487202
-
Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA. Genetics in medicine : official journal of the American College of Medical Genetics. 2013; 15(12):933-40. NIHMSID: NIHMS486583
-
Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA
-
The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Avalos LA, Chen H, Yang C, Andrade SE, Cooper WO, Cheetham CT, Davis RL, Dublin S, Hammad TA, Kaplan S, Pawloski PA, Raebel MA, Scott PE, Smith DH, Toh S, Li DK. Maternal and child health journal. 2014; 18(1):64-72. NIHMSID: NIHMS447348
-
Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC. Dudek AZ, Kumar P, H Thaw SS, Cao Q, Pawloski P, Larson T. American journal of clinical oncology. 2014; 37(2):140-3.
-
Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer. Lash TL, Thwin SS, Yood MU, Geiger AM, Bosco J, Quinn VP, Field TS, Pawloski PA, Silliman RA. Breast cancer research and treatment. 2014; 144(3):643-63. NIHMSID: NIHMS571923
-
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Jordan JH, Thwin SS, Lash TL, Buist DS, Field TS, Haque R, Pawloski PA, Petersen HV, Prout MN, Quinn VP, Yood MU, Silliman RA, Geiger AM. Breast cancer research and treatment. 2014; 146(2):401-9. NIHMSID: NIHMS606305
-
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF. Current medical research and opinion. 2014; 30(8):1687-99.
-
Chronic opioid use emerging after bariatric surgery. Raebel MA, Newcomer SR, Bayliss EA, Boudreau D, DeBar L, Elliott TE, Ahmed AT, Pawloski PA, Fisher D, Toh S, Donahoo WT. Pharmacoepidemiology and drug safety. 2014; 23(12):1247-57.
